Inventor · disambiguated record
Bryan K. Sorensen
Also filed as: SORENSEN BRYAN K · SORENSEN Bryan
40 granted patents·10 pending applications·642 citations·filing 1995–2016
98Inventor score
Top patents by PatentIndex Score
50 records- 0197US6583180B2Glucocorticoid receptor modulatorsABBOTT LAB·Filed 2002·Granted Jun 24, 2003·80 cites·75 claims
- 0297US6521619B2Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agentsICOS CORP·Filed 2001·Granted Feb 18, 2003·103 cites·9 claims
- 0396US5767144AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Jun 16, 1998·90 cites·30 claims
- 0495US7365093B2Endothelin antagonistsABBOTT LAB·Filed 2005·Granted Apr 29, 2008·18 cites·1 claims
- 0594US7217838B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted May 15, 2007·26 cites·27 claims
- 0693US6946481B1Endothelin antagonistsABBOTT LAB·Filed 2002·Granted Sep 20, 2005·37 cites·26 claims
- 0792US6162927AEndothelin antagonistsABBOTT LAB·Filed 1997·Granted Dec 19, 2000·46 cites·10 claims
- 0891US7511175B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2006·Granted Mar 31, 2009·18 cites·15 claims
- 0990US8975398B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 10, 2015·13 cites·13 claims
- 1089US7880001B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzymeABBOTT LAB·Filed 2005·Granted Feb 1, 2011·9 cites·31 claims
- 1189US7208517B1Endothelin antagonistsABBOTT LABORTORIES·Filed 2000·Granted Apr 24, 2007·35 cites·8 claims
- 1286US6462194B1Endothelin antagonistsABBOTT LAB·Filed 2000·Granted Oct 8, 2002·14 cites·9 claims
- 1386US6380241B1Treatment of diseases using endothelin antagonistsABBOTT LAB·Filed 2000·Granted Apr 30, 2002·13 cites·6 claims
- 1485US7528282B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2007·Granted May 5, 2009·7 cites·36 claims
- 1583US9187472B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 17, 2015·5 cites·1 claims
- 1683US5622971AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Apr 22, 1997·25 cites·22 claims
- 1781US6221865B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Apr 24, 2001·30 cites·15 claims
- 1879US6204293B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Mar 20, 2001·26 cites·15 claims
- 1976US9193723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Nov 24, 2015·2 cites·18 claims
- 2076US6124341AEndothelin antagonistsABBOTT LAB·Filed 1998·Granted Sep 26, 2000·21 cites·36 claims
- 2176US5731434AEndothelin antagonistsABBOTT LAB·Filed 1995·Granted Mar 24, 1998·15 cites·8 claims
- 2275US8354422B2Pyrimidine inhibitors of kinase activityABBOTT LAB·Filed 2010·Granted Jan 15, 2013·2 cites·18 claims
- 2374US9296723B2NAMPT inhibitorsABBVIE INC·Filed 2013·Granted Mar 29, 2016·1 cites·8 claims
- 2473US9302989B2NAMPT and rock inhibitorsCURTIN MICHAEL L·Filed 2011·Granted Apr 5, 2016·4 cites·20 claims
- 2572US8415354B2Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2009·Granted Apr 9, 2013·1 cites·2 claims
- 2664USRE41135EInhibitors of the 11-β-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2008·Granted Feb 16, 2010·0 cites·27 claims
- 2762US2009192198A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2009·Application pending·0 cites
- 2861US9051315B2Imidazopyridines as a novel scaffold for multi-targeted kinase inhibitionBA-MAUNG NWE Y·Filed 2010·Granted Jun 9, 2015·1 cites·4 claims
- 2961US8198331B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2009·Granted Jun 12, 2012·0 cites·10 claims
- 3060US2010152179A9Treatment of central nervous system disordersABBOTT LAB·Filed 2008·Application pending·0 cites
- 3158US9464072B2Treatment of central nervous system disordersABBVIE INC·Filed 2014·Granted Oct 11, 2016·0 cites·11 claims
- 3256US9290444B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2014·Granted Mar 22, 2016·0 cites·6 claims
- 3356US9133145B2Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2013·Granted Sep 15, 2015·0 cites·19 claims
- 3455US9758511B2NAMPT inhibitorsABBVIE INC·Filed 2016·Granted Sep 12, 2017·0 cites·7 claims
- 3554US8716345B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted May 6, 2014·0 cites·9 claims
- 3652US8940902B2Treatment of central nervous system disordersBITNER R SCOTT·Filed 2012·Granted Jan 27, 2015·0 cites·1 claims
- 3752US2016184281A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 3852US2017065575A1Nampt inhibitorsABBVIE INC·Filed 2016·Application pending·0 cites
- 3952US2017135994A9Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 4051US8993632B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeBITNER R SCOTT·Filed 2012·Granted Mar 31, 2015·0 cites·18 claims
- 4148US8372841B2Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2011·Granted Feb 12, 2013·0 cites·13 claims
- 4248US8067409B2Protein kinase inhibitorsBA-MAUNG NWE Y·Filed 2008·Granted Nov 29, 2011·0 cites·12 claims
- 4347US2015141398A1Nampt inhibitorsABBVIE INC·Filed 2015·Application pending·0 cites
- 4445US2015265613A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBVIE INC·Filed 2015·Application pending·0 cites
- 4543US2004209928A1Glucagon receptor antagonists/inverse agonistsFiled 2003·Application pending·0 cites
- 4643US2010222316A1Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzymeABBOTT LAB·Filed 2010·Application pending·0 cites
- 4739US10093624B2NAMPT and ROCK inhibitorsABBVIE INC·Filed 2015·Granted Oct 9, 2018·0 cites·18 claims
- 4838US8691810B2Pyrrolopyridine and pyrrolopyrimidine inhibitors of kinasesMICHAELIDES MICHAEL R·Filed 2011·Granted Apr 8, 2014·0 cites·17 claims
- 4935US8536180B2Pyrimidine inhibitors of kinase activityCLARK RICHARD F·Filed 2010·Granted Sep 17, 2013·0 cites·25 claims
- 5029US2012122924A1Nampt inhibitorsCURTIN MICHAEL L·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →